These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3781347)

  • 1. Plasma progesterone and androstenedione in relation to changes in tumor volume and recurrence in women with ovarian carcinoma.
    Mählck CG; Bäckström T; Kjellgren O; von Schoultz B
    Gynecol Obstet Invest; 1986; 22(3):157-64. PubMed ID: 3781347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androstenedione production by malignant epithelial ovarian tumors.
    Mählck CG; Bäckström T; Kjellgren O
    Gynecol Oncol; 1986 Oct; 25(2):217-22. PubMed ID: 3758832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma steroid hormones in women with epithelial ovarian carcinoma.
    Mählck CG
    Acta Obstet Gynecol Scand Suppl; 1986; 137():1-31. PubMed ID: 3468734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma level of estradiol in patients with ovarian malignant tumors.
    Mählck CG; Bäckström T; Kjellgren O
    Gynecol Oncol; 1988 Jul; 30(3):313-20. PubMed ID: 3391418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone as a possible tumor marker for "nonendocrine" ovarian malignant tumors.
    Bäckström T; Mählck CG; Kjellgren O
    Gynecol Oncol; 1983 Aug; 16(1):129-38. PubMed ID: 6884825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 20 alpha-OH-progesterone in women with malignant epithelial 'non-endocrine' ovarian tumors.
    Mählck CG; Bäckström T; Kjellgren O; Selstam G
    Acta Obstet Gynecol Scand; 1985; 64(6):515-8. PubMed ID: 4061067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone, SHBG and albumin in patients with ovarian carcinoma.
    Mählck CG; Grankvist K; Bäckström T; Kjellgren O
    Acta Obstet Gynecol Scand; 1986; 65(6):533-8. PubMed ID: 3799148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of initial plasma steroid concentrations in the prognosis of 'nonendocrine' malignant ovarian tumors.
    Mählck CG; Bäckström T; Kjellgren O
    Gynecol Obstet Invest; 1989; 28(1):41-6. PubMed ID: 2777133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CA 125 and progesterone production in women with ovarian carcinoma.
    Mählck CG; Grankvist K; Kjellgren O; Bäckström T
    Cancer; 1990 May; 65(9):2058-63. PubMed ID: 2372770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma androstenedione and oestrone levels before and after the menopause. II. Non-endocrine ovarian tumours and cysts.
    Mango D; Scirpa P; Battaglia F; Scirpa S; Montemurro A
    Maturitas; 1982 Apr; 4(1):43-8. PubMed ID: 7099002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prealbumin in women with epithelial ovarian carcinoma.
    Mählck CG; Grankvist K
    Gynecol Obstet Invest; 1994; 37(2):135-40. PubMed ID: 8150370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol, progesterone, 17-hydroxyprogesterone, androstenedione and CA125 in patients with ovarian carcinoma.
    Maneschi F; Geraci P; Barreca PV; Palisi F; Adragna F; Napoli M
    Gynecol Endocrinol; 1992 Mar; 6(1):25-30. PubMed ID: 1580164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of steroid hormones in patients with ovarian cancer.
    Mango D; Scirpa P; Battaglia F; Tartaglia E; Manna P
    J Endocrinol Invest; 1986 Aug; 9(4):307-14. PubMed ID: 3782744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated progesterone levels in serum and ovarian venous blood in patients with ovarian tumors.
    Heinonen PK; Koivula T; Pystynen P
    Acta Obstet Gynecol Scand; 1985; 64(8):649-52. PubMed ID: 3832755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of progesterone and androgens on the growth of endometrial carcinoma.
    Boman K; Strang P; Bäckström T; Stendahl U
    Cancer; 1993 Jun; 71(11):3565-9. PubMed ID: 8490905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid production in different parts of malignant and benign ovarian tumors in vitro.
    Ridderheim M; Mählck CG; Selstam G; Stendahl U; Bäckström T
    Cancer Res; 1993 May; 53(10 Suppl):2309-12. PubMed ID: 8485717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone androstenedione testosterone and clinical characteristics in endometrial carcinoma.
    Boman K; Bäckström T; Gerdes U; Stendahl U
    Anticancer Res; 1991; 11(6):2163-6. PubMed ID: 1776856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hormonal activity of the postmenopausal ovary.
    Vermeulen A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):247-53. PubMed ID: 177438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.